5,11-Epoxynaphthacene-3-carboxamide,5a-chloro-1-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-2,4a,7,12-tetrahydroxy-11-methyl-4,6-dioxo-5-(sulfooxy)- (62288-14-6)

Identification
Name:	5,11-Epoxynaphthacene-3-carboxamide,5a-chloro-1-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-2,4a,7,12-tetrahydroxy-11-methyl-4,6-dioxo-5-(sulfooxy)-
CAS:	62288-14-6
Molecular Formula:	C₂₂H₂₃ClN₂O₁₂S
Molecular Structure:
Properties
Safety Data

Other Product

2-Naphthacenecarboxamide, 11a-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-3,5,10,12a-tetrahydroxy-6-methylene-1,11,12-trioxo-, [4S-(4α,4aα,5α,5aα,11aβ,12aα)]-
5,11-Epoxynaphthacene-3-carboxamide,5a-chloro-1-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-2,4a,5,7,12-pentahydroxy-11-methyl-4,6-dioxo-,(1S,4aS,5S,5aS,11S,11aR,12S,12aR)-
5,11-Epoxynaphthacene-3-carboxamide,5a-chloro-1-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-2,4a,5,7,12-pentahydroxy-11-methyl-4,6-dioxo-, monohydrochloride
5,11-Epoxynaphthacene-3-carboxamide,5a-chloro-1-(dimethylamino)-1,4,4a,5,5a,6,11,11a-octahydro-2,4a,5,7,12-pentahydroxy-11-methyl-4,6-dioxo-
Spiro[2-cyclohexene-1,2'(1'H)-cyclopenta[de]naphthacene]-9'-carboxamide,7',7'a,8',11',11'a,12'-hexahydro-5',6',7'a,10',11'a,12'-hexahydroxy-3'-methoxy-2,6,6-trimethyl-7',8'-dioxo-,(1R,7'aR,11'aR,12'R)-rel-(-)-
5,11-Epoxynaphthacene-3-carboxamide, 5a-chloro-1-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-2,4a,5,7,12-pentahydroxy-11-methyl-4,6-dioxo-, monohydrochloride, (1S-(1alpha,4alpha,5beta,5aalpha,11beta,11aalpha,12alpha,12aalpha))-
1/C7H10N4O/c1-2-9-10-7(8-1)11-3-5-12-6-4-11/h1-2H,3-6H
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
1/C12H17NO2/c14-11-4-2-1-3-9(11)7-10-8-12(5-6-12)15-13-10/h9H,1-8H
(3E)-3-[amino(hydroxy)methylidene]-5a-chloro-1-(dimethylamino)-4a,5,7,12-tetrahydroxy-11-methyl-5,5a,11,11a,12,12a-hexahydro-5,11-epoxytetracene-2,4,6(1H,3H,4aH)-trione
Benzo[a]naphthacene-2-carboxamide,N-(2-amino-1-methyl-2-oxoethyl)-5-[[4,6-dideoxy-4-(methylamino)-3-O-b-D-xylopyranosyl-b-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-,[5S-[2(S*),5a,6b]]- (9CI)
Spiro[2-cyclohexene-1,2'(1'H)-cyclopenta[de]naphthacene]-9'-carboxamide,6'-(b-D-glucopyranosyloxy)-7',7'a,8',11',11'a,12'-hexahydro-5',7'a,10',11'a,12'-pentahydroxy-3'-methoxy-2,6,6-trimethyl-7',8'-dioxo-,[2'S-(2'a,7'ab,11'ab,12'b)]- (9CI)
Spiro[furan-3(2H),7'(4'H)-naphtho[2,1-g]quinoline]-4',5,6',10'(4H,6'aH,7'aH)-tetrone,1',4'a,5',8',9',11',12'a,12'b-octahydro-2',5',7'a,12'a-tetramethyl-11'-[[(2R,4R)-tetrahydro-4-methyl-5-oxo-2-furanyl]methyl]-,(3S,4'aS,5'S,6'aR,7'aR,12'aS,12'bS)-rel-(+)- (9CI)
b-D-Galactopyranoside, (3b,4a,11a,16b,21a)-16,21,23,28-tetrahydroxy-11-methoxyolean-12-en-3-ylO-b-D-glucopyranosyl-(1®2)-O-[b-D-glucopyranosyl-(1®3)]-6-deoxy- (9CI)
Metaphosphoric acid (HPO3), compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (4:3), monosodium salt
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide (1:1)
1/C8H7NO3/c10-8-3-1-7(2-4-8)5-6-9(11)12/h1-6,10H/b6-5